---
title: "AdhereBio LLC SEC filings"
url: https://altstreet.investments/edgar/2160633
kind: edgar-entity
updated: 2026-10-28
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# AdhereBio LLC: SEC filings and what they report

AdhereBio LLC is a Delaware-organized entity that filed a Form D for an equity offering under Rule 506(b) on 2026-10-26, with Shawn Barrieau listed as the sole related executive officer. The filing is pre-open, with no amount sold, investor count, or first sale date yet disclosed, and a stated minimum investment of $100,000. No parent platform or related filings from this manager were identified in available records.

| Field | Value |
| --- | --- |
| Entity | AdhereBio LLC |
| CIK | 2160633 |
| Filing family | 506(b) |
| Entity type | platform company |
| Newest fact-bearing filing | October 26, 2026, accession 0002134718-26-000101 |
| Total offering amount (as filed) | $5,000,000 |
| Total sold (as reported) | $0 |
| Investors (as reported) | 0 |
| Minimum investment (as filed) | $100,000 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| Shawn Barrieau | Executive Officer |


## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| October 26, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2160633/000213471826000101/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2160633
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002160633&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2160633
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
